BioCardia Inc (BCDA)
2.35
-0.05
(-2.08%)
USD |
NASDAQ |
Nov 13, 16:00
2.35
0.00 (0.00%)
After-Hours: 20:00
BioCardia Research and Development Expense (Quarterly): 0.80M for June 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.80M |
| March 31, 2024 | 1.241M |
| December 31, 2023 | 1.156M |
| September 30, 2023 | 1.872M |
| June 30, 2023 | 2.314M |
| March 31, 2023 | 2.384M |
| December 31, 2022 | 2.20M |
| September 30, 2022 | 2.144M |
| June 30, 2022 | 2.304M |
| March 31, 2022 | 2.186M |
| December 31, 2021 | 2.115M |
| September 30, 2021 | 2.24M |
| June 30, 2021 | 2.362M |
| March 31, 2021 | 1.841M |
| December 31, 2020 | 2.325M |
| September 30, 2020 | 2.474M |
| June 30, 2020 | 2.224M |
| March 31, 2020 | 2.786M |
| December 31, 2019 | 2.17M |
| September 30, 2019 | 2.007M |
| June 30, 2019 | 2.219M |
| March 31, 2019 | 2.166M |
| December 31, 2018 | 2.205M |
| September 30, 2018 | 2.262M |
| June 30, 2018 | 2.031M |
| Date | Value |
|---|---|
| March 31, 2018 | 1.955M |
| December 31, 2017 | 1.771M |
| September 30, 2017 | 1.70M |
| June 30, 2017 | 1.295M |
| March 31, 2017 | 1.033M |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.80M
Minimum
Jun 2024
2.786M
Maximum
Mar 2020
2.060M
Average
2.20M
Median
Dec 2022
Research and Development Expense (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 270.93M |
| The Cooper Companies Inc | 39.00M |
| Theriva Biologics Inc | 2.953M |
| Zevra Therapeutics Inc | 10.52M |
| Instil Bio Inc | 2.921M |